These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 21160042)
1. Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types. Chiang EY; Yu X; Grogan JL J Immunol; 2011 Jan; 186(2):1279-88. PubMed ID: 21160042 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus. Lech M; Kantner C; Kulkarni OP; Ryu M; Vlasova E; Heesemann J; Anz D; Endres S; Kobayashi KS; Flavell RA; Martin J; Anders HJ Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872 [TBL] [Abstract][Full Text] [Related]
3. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674 [TBL] [Abstract][Full Text] [Related]
5. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound. Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806 [TBL] [Abstract][Full Text] [Related]
6. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice. Pau E; Chang NH; Loh C; Lajoie G; Wither JE Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847 [TBL] [Abstract][Full Text] [Related]
7. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Kawagoe T; Sato S; Matsushita K; Kato H; Matsui K; Kumagai Y; Saitoh T; Kawai T; Takeuchi O; Akira S Nat Immunol; 2008 Jun; 9(6):684-91. PubMed ID: 18438411 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370 [TBL] [Abstract][Full Text] [Related]
10. T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2-MyD88-dependent T cell activation. Schmaler M; Jann NJ; Ferracin F; Landmann R J Immunol; 2011 Jan; 186(1):443-52. PubMed ID: 21131426 [TBL] [Abstract][Full Text] [Related]
11. IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. Zhang X; Jin J; Tang Y; Speer D; Sujkowska D; Markovic-Plese S J Immunol; 2009 Mar; 182(6):3928-36. PubMed ID: 19265172 [TBL] [Abstract][Full Text] [Related]
12. IFN-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1β and LFA-1. Hagberg N; Berggren O; Leonard D; Weber G; Bryceson YT; Alm GV; Eloranta ML; Rönnblom L J Immunol; 2011 May; 186(9):5085-94. PubMed ID: 21430220 [TBL] [Abstract][Full Text] [Related]
13. Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity. Fousteri G; Liossis SN; Battaglia M Clin Immunol; 2013 Dec; 149(3):556-65. PubMed ID: 24269925 [TBL] [Abstract][Full Text] [Related]
14. Regulatory B cells in autoimmune diseases: how do they work? Lemoine S; Morva A; Youinou P; Jamin C Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160 [TBL] [Abstract][Full Text] [Related]
15. Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Eloranta ML; Lövgren T; Finke D; Mathsson L; Rönnelid J; Kastner B; Alm GV; Rönnblom L Arthritis Rheum; 2009 Aug; 60(8):2418-27. PubMed ID: 19644885 [TBL] [Abstract][Full Text] [Related]
16. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. Meyers JA; Mangini AJ; Nagai T; Roff CF; Sehy D; van Seventer GA; van Seventer JM Cytokine; 2006 Sep; 35(5-6):235-46. PubMed ID: 17052915 [TBL] [Abstract][Full Text] [Related]
17. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential. Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775 [TBL] [Abstract][Full Text] [Related]
18. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells. Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169 [TBL] [Abstract][Full Text] [Related]
19. Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-β signaling. Bourgeois C; Majer O; Frohner IE; Lesiak-Markowicz I; Hildering KS; Glaser W; Stockinger S; Decker T; Akira S; Müller M; Kuchler K J Immunol; 2011 Mar; 186(5):3104-12. PubMed ID: 21282509 [TBL] [Abstract][Full Text] [Related]
20. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]